Reports for HIKMA CANADA LIMITED

Company Name

HIKMA CANADA LIMITED

Totals

Shortage reports

49

Actual shortage: 5 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 44 (90%)

Discontinuation Reports

3

To be discontinued: 3 (100%)
Discontinued: 0 (0%)
Reversed: 0 (0%)

Late reports

14 (27%)

Overdue reports

5 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACETYLCYSTEINE SOLUTION USP 200MG SOLUTION Resolved 2018-07-12 2018-09-04 55518
ACETYLCYSTEINE SOLUTION USP 200MG SOLUTION Resolved 2019-05-28 2021-04-22 85112
ACETYLCYSTEINE SOLUTION USP 200MG SOLUTION Resolved 2022-10-06 2023-01-24 171228
ACETYLCYSTEINE SOLUTION USP 200MG SOLUTION Actual shortage 2022-10-21 2022-11-18 172409
ATROPINE INJECTION BP 0.4MG SOLUTION Resolved 2018-08-10 2018-09-04 57885
CYANOCOBALAMIN INJECTION USP 1000MCG LIQUID Resolved 2019-10-03 2020-02-04 95366
DIAZEPAM INJECTION USP 5MG SOLUTION Resolved 2018-09-27 2019-05-04 62442
DIAZEPAM INJECTION USP 5MG SOLUTION Actual shortage 2020-05-20 2020-05-21 115413
DIMENHYDRINATE INJECTION USP 50MG SOLUTION Resolved 2022-04-14 2022-06-07 158877
DIMENHYDRINATE INJECTION USP 50MG SOLUTION Resolved 2018-02-15 2018-05-16 39961
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2017-12-22 2018-07-09 34254
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2018-09-27 2018-11-30 62439
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2019-01-22 2019-01-30 73273
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2019-02-19 2019-06-19 76329
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2019-12-20 2020-02-21 101864
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2022-03-30 2022-04-28 157571
EPINEPHRINE INJECTION USP 1MG SOLUTION Resolved 2022-06-20 2022-08-16 163112
ERGONOVINE MALEATE INJECTION USP 0.25MG SOLUTION Resolved 2019-03-11 2019-04-18 78235
ERGONOVINE MALEATE INJECTION USP 0.25MG SOLUTION Resolved 2021-05-14 2021-09-04 139434
FENTANYL CITRATE INJECTION USP 50MCG SOLUTION Resolved 2018-08-22 2018-10-11 58777

Showing 1 to 20 of 49

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165188
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.375G 3G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165193
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.5G 4G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165196

Showing 1 to 3 of 3